Increased Healthcare Utilization in Hidradenitis Suppurativa and Arthritis: A Propensity Score-Matched Analysis from a Hospital-Based Cohort
Skin Appendage Disorders · 17.11.2026 · 12 (5) · 333-341
DOI: 10.1159/000551410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Skin Appendage Disorders, online erschienen am 06.03.2026. Verfasst von Patricia Garbayo-Salmons und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Bar…. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CERCA Programme/Generalitat de Catalunya.
Abstract (Originalsprache)
Introduction
Hidradenitis suppurativa (HS) has been linked to arthritis, but large real-world analyses remain limited. This study evaluated the prevalence, risk, and clinical impact of arthritis in patients with HS, focusing on healthcare use.
Methods
A retrospective multicenter cohort was assembled using the TriNetX network. Adults with HS (n = 226,047) were compared with matched controls without HS (n = 12,286,573). Arthritis prevalence, 5-year risk, and healthcare utilization were assessed after 1:1 propensity score matching.
Results
Arthritis prevalence was higher in the HS group (6.22% vs. 5.66%). Over 5 years, HS patients had a higher risk of arthritis than the general hospital population (2.22% vs. 1.73%; risk ratio 1.29, 95% CI: 1.23–1.34). Within the HS cohort, those with arthritis showed greater use of systemic therapies, including tumor necrosis factor inhibitors (27% vs. 6%) and interleukin inhibitors (12% vs. 2%). They also had more outpatient visits, emergency visits, and hospitalizations across 1-, 3-, and 5-year periods.
Conclusions
Findings should be interpreted considering the limitations of administrative datasets, including potential misclassification and underreporting. Overall, HS is associated with a higher 5-year risk (cumulative incidence) of arthritis, and patients with both conditions exhibit substantially increased healthcare use.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Spain.
- Departament de Medicina, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
- Department of Rheumatology, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Spain.
Förderung
- CERCA Programme/Generalitat de Catalunya
Zitieren
APA
Garbayo-Salmons, P., Rodrigo-Parés, A., Saus, E., Moreno, M., Carreras, A., Feliu-Hernàndez, C., Exposito-Serrano, V., Ribera, M., Sabat, M., & Calvet, J. (2026). Increased Healthcare Utilization in Hidradenitis Suppurativa and Arthritis: A Propensity Score-Matched Analysis from a Hospital-Based Cohort. Skin Appendage Disorders, 12(5), 333-341. https://doi.org/10.1159/000551410
Vancouver
Garbayo-Salmons P, Rodrigo-Parés A, Saus E, Moreno M, Carreras A, Feliu-Hernàndez C, et al. Increased Healthcare Utilization in Hidradenitis Suppurativa and Arthritis: A Propensity Score-Matched Analysis from a Hospital-Based Cohort. Skin Appendage Disorders. 2026;12(5):333-341. doi:10.1159/000551410
BibTeX
@article{GarbayoSalmons2026,
author = {Garbayo-Salmons, Patricia and Rodrigo-Parés, Albert and Saus, Ester and Moreno, Mireia and Carreras, Anna and Feliu-Hernàndez, Clara and Exposito-Serrano, Vicente and Ribera, Miquel and Sabat, Mireia and Calvet, Joan},
title = {Increased Healthcare Utilization in Hidradenitis Suppurativa and Arthritis: A Propensity Score-Matched Analysis from a Hospital-Based Cohort},
journal = {Skin Appendage Disorders},
year = {2026},
volume = {12},
number = {5},
pages = {333--341},
doi = {10.1159/000551410}
}
EUVIMED